Click for best price
Brain Cancer Molecular Diagnostics Market Size, Share 2023
A molecular approach for diagnosing brain cancer
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Molecular Diagnostics. This report contains market size and forecasts of Brain Cancer Molecular Diagnostics in global, including the following market information:
Global Brain Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Brain Cancer Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Brain Cancer Molecular Diagnostics include Genetronhealth, Premed, Gene+, DMDbiomed, Helixgen, Annoroad, Geneis, Unitedgene and Inmedi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Brain Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Brain Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Brain Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Brain Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Brain Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Brain Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Brain Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genetronhealth
Premed
Gene+
DMDbiomed
Helixgen
Annoroad
Geneis
Unitedgene
Inmedi
Qiagen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Brain Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Brain Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Brain Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Brain Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Brain Cancer Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Brain Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Brain Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Brain Cancer Molecular Diagnostics Overall Market Size
2.1 Global Brain Cancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Brain Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Brain Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Brain Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Brain Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Brain Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Brain Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Brain Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Brain Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Brain Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Brain Cancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Brain Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Brain Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Brain Cancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Brain Cancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Brain Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Brain Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Brain Cancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Brain Cancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Brain Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Brain Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Brain Cancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Brain Cancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Brain Cancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Brain Cancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Brain Cancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Brain Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Brain Cancer Molecular Diagnostics Market Size, 2018-2030
7 Brain Cancer Molecular Diagnostics Companies Profiles
7.1 Genetronhealth
7.1.1 Genetronhealth Company Summary
7.1.2 Genetronhealth Business Overview
7.1.3 Genetronhealth Brain Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Genetronhealth Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Genetronhealth Key News & Latest Developments
7.2 Premed
7.2.1 Premed Company Summary
7.2.2 Premed Business Overview
7.2.3 Premed Brain Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Premed Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Premed Key News & Latest Developments
7.3 Gene+
7.3.1 Gene+ Company Summary
7.3.2 Gene+ Business Overview
7.3.3 Gene+ Brain Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Gene+ Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Gene+ Key News & Latest Developments
7.4 DMDbiomed
7.4.1 DMDbiomed Company Summary
7.4.2 DMDbiomed Business Overview
7.4.3 DMDbiomed Brain Cancer Molecular Diagnostics Major Product Offerings
7.4.4 DMDbiomed Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 DMDbiomed Key News & Latest Developments
7.5 Helixgen
7.5.1 Helixgen Company Summary
7.5.2 Helixgen Business Overview
7.5.3 Helixgen Brain Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Helixgen Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Helixgen Key News & Latest Developments
7.6 Annoroad
7.6.1 Annoroad Company Summary
7.6.2 Annoroad Business Overview
7.6.3 Annoroad Brain Cancer Molecular Diagnostics Major Product Offerings
7.6.4 Annoroad Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Annoroad Key News & Latest Developments
7.7 Geneis
7.7.1 Geneis Company Summary
7.7.2 Geneis Business Overview
7.7.3 Geneis Brain Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Geneis Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Geneis Key News & Latest Developments
7.8 Unitedgene
7.8.1 Unitedgene Company Summary
7.8.2 Unitedgene Business Overview
7.8.3 Unitedgene Brain Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Unitedgene Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Unitedgene Key News & Latest Developments
7.9 Inmedi
7.9.1 Inmedi Company Summary
7.9.2 Inmedi Business Overview
7.9.3 Inmedi Brain Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Inmedi Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Inmedi Key News & Latest Developments
7.10 Qiagen
7.10.1 Qiagen Company Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Brain Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Qiagen Brain Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Qiagen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Brain Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Brain Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Brain Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Brain Cancer Molecular Diagnostics in Global Market
Table 5. Top Brain Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Brain Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Brain Cancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Brain Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Brain Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Brain Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Brain Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Brain Cancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Brain Cancer Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Genetronhealth Company Summary
Table 31. Genetronhealth Brain Cancer Molecular Diagnostics Product Offerings
Table 32. Genetronhealth Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Genetronhealth Key News & Latest Developments
Table 34. Premed Company Summary
Table 35. Premed Brain Cancer Molecular Diagnostics Product Offerings
Table 36. Premed Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Premed Key News & Latest Developments
Table 38. Gene+ Company Summary
Table 39. Gene+ Brain Cancer Molecular Diagnostics Product Offerings
Table 40. Gene+ Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Gene+ Key News & Latest Developments
Table 42. DMDbiomed Company Summary
Table 43. DMDbiomed Brain Cancer Molecular Diagnostics Product Offerings
Table 44. DMDbiomed Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. DMDbiomed Key News & Latest Developments
Table 46. Helixgen Company Summary
Table 47. Helixgen Brain Cancer Molecular Diagnostics Product Offerings
Table 48. Helixgen Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Helixgen Key News & Latest Developments
Table 50. Annoroad Company Summary
Table 51. Annoroad Brain Cancer Molecular Diagnostics Product Offerings
Table 52. Annoroad Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Annoroad Key News & Latest Developments
Table 54. Geneis Company Summary
Table 55. Geneis Brain Cancer Molecular Diagnostics Product Offerings
Table 56. Geneis Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Geneis Key News & Latest Developments
Table 58. Unitedgene Company Summary
Table 59. Unitedgene Brain Cancer Molecular Diagnostics Product Offerings
Table 60. Unitedgene Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Unitedgene Key News & Latest Developments
Table 62. Inmedi Company Summary
Table 63. Inmedi Brain Cancer Molecular Diagnostics Product Offerings
Table 64. Inmedi Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Inmedi Key News & Latest Developments
Table 66. Qiagen Company Summary
Table 67. Qiagen Brain Cancer Molecular Diagnostics Product Offerings
Table 68. Qiagen Brain Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Qiagen Key News & Latest Developments
List of Figures
Figure 1. Brain Cancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Brain Cancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Brain Cancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Brain Cancer Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Brain Cancer Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Brain Cancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Brain Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Brain Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Genetronhealth Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Premed Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Gene+ Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. DMDbiomed Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Helixgen Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Annoroad Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Geneis Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Unitedgene Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Inmedi Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Qiagen Brain Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
